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IL-10-Producing Langerhans Cells and Regulatory
T Cells Are Responsible for Depressed Contact
Hypersensitivity in Grafted Skin
Ryutaro Yoshiki1, Kenji Kabashima1, Kazunari Sugita1, Kenji Atarashi1, Takatoshi Shimauchi1 and
Yoshiki Tokura1
Although skin grafting is a common surgical technique, the immunological state of grafted skin remains
unelucidated. An experimental model has shown that the development of murine contact hypersensitivity
(CHS) is depressed when mice are sensitized with a hapten through full-thickness grafted skin. We explored the
immunological mechanisms underlying this hyposensitization, focusing on the fate of Langerhans cells (LCs).
When FITC was applied to grafted skin, FITC-bearing LCs were capable of migrating to the draining lymph
nodes. Epidermal cell suspensions isolated from the grafted skin produced a high amount of IL-10 as assessed
by real-time PCR. Adoptive transfer of immune lymph node cells from the sensitized mice suppressed the CHS
response of recipients in an antigen-specific manner. CD4þCD25þ but not CD4þCD25 T cells purified from
lymph node cells were responsible for this suppression. Finally, we detected high expression of receptor
activators of nuclear factor k-B ligand (RANKL) in the grafted skin, and found that recombinant RANKL
stimulated LCs to produce IL-10. These findings suggest that the hyposensitization of CHS through the grafted
skin is not attributable merely to the reduction of LC number but that IL-10-producing LCs exert a
downmodulatory effect by inducing regulatory T cells.
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INTRODUCTION
Skin grafting is frequently employed in dermatology and
plastic surgery. Skin grafts from the same individual can be
successfully implemented 7 days after an operation, and they
survive throughout the patient’s life. Full-thickness skin grafts
exhibit a well-matched appearance, whereas thin-thickness
grafts match poorly in texture. Although there have been
many cosmetic studies on skin grafting, little is known about
the immunological state or the fate of immunocompetent
cells in grafted skin. In particular, the function of Langerhans
cells (LCs) in grafted skin is poorly understood. Clinical
observations have suggested impaired immunity in grafted
skin (Doiurnon et al., 2001), and the lack of dermatitis on the
graft is empirically known; therefore, some immunological
alterations are thought to take place in the graft. Only one
study has demonstrated that murine contact hypersensitivity
(CHS) to a hapten cannot develop upon sensitization through
full-thickness grafted skin (Yasuda et al., 1996).
LCs are the major immunocompetent cells in the skin
(Katz et al., 1979; Stingl et al., 1980) and have a positive
(Silberberg-Sinakin and Thorbecke, 1980) or, in certain
conditions, suppressive (Kaplan et al., 2005) role in the
development of CHS. They take up external antigens, migrate
to draining lymph nodes, and present the antigenic determi-
nant to naive T cells in the context of major histocompat-
ibility complex (MHC) molecules. Thus, LCs are critical in
sampling and presenting antigens in the skin. Recent studies
have disclosed an immunoregulatory role of LCs. These
epidermal dendritic cells (DCs) may exert a suppressive effect
when they produce IL-10 (Kang et al., 1998; Flacher et al.,
2006). This is consistent with the observation that IL-10
production by pulmonary DCs is critical for the induction of
tolerance (Akbari et al., 2001). Recently, it has been shown
that receptor activators of nuclear factor k-B ligand (RANKL)
produced in UV light-irradiated epidermis mediate immuno-
suppression by modulating LCs (Loser et al., 2007).
In this study, we explored the fate and functional
alterations of LCs in full-thickness grafted skin using a murine
CHS experimental system. Our results suggest that the
immunological tolerance induced by sensitization through
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the grafted skin is mediated by IL-10-producing LCs after the
induction of CD4þCD25þ regulatory T (Treg) cells. Over-
expressed RANKL in the keratinocytes of grafted skin may
stimulate LCs to produce IL-10.
RESULTS
Poor development of CHS in mice sensitized with PCl through
grafted skin
To confirm the previous observation by Yasuda et al. (1996)
and to further examine whether the suppression of CHS by
sensitization through skin grafting is a local or systemic
phenomenon, mice were sensitized with picryl chloride (PCl)
through grafted dorsal skin or non-grafted abdominal skin
after skin graft implementation (on day 7 after operation).
When PCl was applied to the grafted area for sensitization,
the ear swelling challenge response was significantly lower
than that of the positive control without skin graft (Figure 1).
In contrast, sensitization of the skin-grafted mice through the
non-grafted abdominal area did not abrogate CHS response.
Similar data were obtained from three independent series of
experiments. Thus, the depressed CHS response occurred
only when sensitization was performed through the grafted
local area.
Numerical alteration and apoptosis of LCs in grafted skin
LCs are critical for CHS, as they serve as antigen-presenting
cells and migrate to the draining lymph nodes (Romani et al.,
2003). We therefore investigated the change in number of
LCs in the grafted skin along with the draining lymph nodes.
Epidermal sheets were taken from the grafted skin on days 7
and 14 after operation and stained with phycoerythrin (PE)-
labeled anti-I-A monoclonal antibody (mAb). The number of
LCs was lower in the grafted skin (200–300mm2) on day 7
than in the untreated control skin (800–1,000mm2). More-
over, the number of LCs in grafted skin returned to normal on
day 14 (data not shown). These results indicate that the LC
number was reduced at the time of sensitization. Morpholo-
gically, LCs in the grafted skin exhibited a round appearance.
This reduction in LC number was not due to the migration of
LCs from the skin, as the number of DCs was not increased in
the regional lymph nodes (data not shown). Epidermal cell
(EC) suspensions from normal skin or grafted skin were
assessed for apoptosis by flow cytometry. The fraction of
apoptosis in LCs was demonstrated as the Annexin-V-positive
propidium iodide–negative subset in the grafted skin
(Figure 2a). The percentage of apoptotic LCs was significantly
increased on day 1 after grafting, but returned to the baseline
on day 4 (Figure 2b).
Phenotypes and numbers of migrating LCs and dermal DCs in
grafted skin
LCs are capable of migrating from the epidermis into the
lymph nodes on sensitization (Kabashima et al., 2003). The
migratory ability of LCs in grafted skin was examined with
FITC, which is not only a hapten but also a cell-tracking
marker. On day 7 after skin grafting, FITC was applied to the
grafted area. Draining lymph node cells were taken 24 hours
later and labeled with allophycocyanin-labeled anti-I-A mAb,
anti-mouse CD205 rat IgG, followed by PE-conjugated anti-
rat IgG mAb. FITCþ MHC class IIþ cells were defined as
migrating DCs from the skin. CD205 is expressed by LCs as
well as by dermal DCs (dDC; Henri et al., 2001). In fact,
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Figure 1. CHS responses in mice sensitized with PCl through grafted or non-
grafted skin. Mice were sensitized with PCl on the grafted back skin or non-
grafted abdominal skin 7 days after skin grafting. PCl was challenged on each
earlobe 5 days after sensitization. The change in ear thickness was measured
24hours later. Data are representative of three independent experiments.
Each group consisted of more than four mice. *Po0.05.
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Figure 2. Numerical and morphological alterations and apoptosis of LCs in
grafted skin. (a) Apoptosis of Langerhans cells in the grafted skin. EC
suspensions from the 1-day grafted or non-grafted skin were stained with
FITC-conjugated MHC class II, APC-conjugated Annexin V and PI. Apoptotic
LCs were defined as MHC class IIþ Annexin Vþ , but PI, whereas necrotic
cells were double positive. (b) Percentage of apoptotic LCs after grafting
procedure. Day 0 represents normal skin and day 1, 4, or 7 shows the day
after grafting. Data are representative of three independent experiments. Each
group consisted of five mice. *Po0.05.
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migrating DCs were divided into a CD205þ Langerinþ
subset and a CD205 Langerin subset. Therefore, the vast
majority of FITCþ MHC class IIhi CD205þ cells represent
LCs, whereas FITCþ MHC class IIhi CD205 cells are mostly
dDCs (Figure 3a).
To determine whether migrating LCs/dDCs in grafted skin
retained their antigen-presenting capacity, migrating DCs
were stained with PE-conjugated mAbs to CD80 and CD86.
CD80 and CD86 were present on both LCs and dDCs. Thus,
LCs/dDCs in grafted skin retained their antigen-presenting
capacity for naive T cells.
Compared to the control mice painted with FITC on
normal skin, the mice sensitized at the skin-grafted site had
reduced numbers of both FITCþ MHC class IIhi CD205þ and
FITCþ MHC class IIhi CD205 populations in the draining
lymph nodes (Figure 3c). From three independent series of
experiments, the number of LCs and/or DCs in the lymph
nodes of grafted skin–sensitized mice was approximately one-
fourth that of normal skin–sensitized mice (Figure 3c).
Considering that the grafted skin originally had about
one-fourth the LCs of normal skin, the migratory ability
of LCs in grafted skin was virtually the same as that in
normal skin.
Increased IL-10 expression in grafted skin
It is well known that UV B (UVB) radiation has immunosup-
pressive effects on normal cutaneous processes (Elmets et al.,
1983; Yagi et al., 1996) and this UV-induced immuno-
suppression is associated with upregulation of anti-inflam-
matory Th2 cytokines, IL-4 and IL-10 (Rivas and Ullrich,
1992; Shreedhar et al., 1998). Among cytokines, IL-10 is
critical for CHS suppression (Simkin et al., 2000), and both
LCs (Takashima, 1995; Flacher et al., 2006) and keratinocytes
(Rivas and Ullrich, 1992) are possible candidates for the IL-10
source. To address the involvement of IL-10, mice receiving
skin grafts (day 0) were either sensitized with PCl (day 7) on
the dorsal grafted skin or untreated. As control, mice without
skin grafts were sensitized with PCl on the dorsal skin or
untreated. EC suspensions were obtained from the dorsal
skin of these four experimental groups (day 8). As shown in
Figure 4a, whereas the normal skin had little or no ability to
elaborate IL-10 irrespective of PCl sensitization, the grafted
skin expressed high levels of IL-10 mRNA, as assessed
by real-time PCR. Relative amounts of mRNA were measured
by the DDCt method (Atarashi et al., 2007). Although
both grafted skin samples with and without subsequent
PCl painting yielded IL-10 mRNA, the nonsensitized
epidermis was more productive; it may be that IL-10
produced by keratinocytes was reduced in proportion to
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Figure 3. Expression of co-stimulatory molecules and number of migrating
DCs in grafted mice. (a) Draining lymph node cells were taken from mice
painted with FITC on the grafted or normal skin and stained with anti-MHC
class II, CD205 and Langerin mAbs. CD205þ cells are virtually the same
population as Langerinþ cells. (b) After being stained with anti-CD205,
CD80, and CD86 mAbs, lymph node cells were subjected to flow cytometric
analysis to assess the expression of co-stimulatory molecules. (c) Numbers of
FITCþ MHC class IIhi CD205þ cells (mainly LCs) and FITCþ MHC class IIhi
CD205 cells (mainly dDCs) migrating from the skin to the draining lymph
nodes. The numbers are calculated based on flow cytometric analysis gated as
seen in Figure 3a. Each group consisted of more than four mice. *Po0.05.
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Figure 4. IL-10 expression in ECs and lymph node cells from grafted mice. (a)
Epidermal sheets were prepared from grafted (7 days after operation) or non-
grafted skin that was painted with PCl or left untreated. IL-10 mRNA
expression was measured by real-time PCR. (b) Draining lymph node cells
were obtained 5 days after sensitization of mice through grafted or non-
grafted skin. IL-10 mRNA expression was measured by real-time PCR. The
relative amounts of mRNA expression were calculated using the DDCt
method. Each group consisted of more than four mice. Data are the
mean±SD of three independent experiments. *Po0.05.
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PCl sensitization or, alternatively, IL-10-producing LCs
emigrated on sensitization.
Along with ECs, we examined the expression of IL-10
mRNA in the draining lymph nodes. Lymph node cells were
prepared from mice receiving skin grafts and/or subsequent
PCl painting. Skin grafting alone did not augment IL-10
production by lymph node cells (Figure 4b). PCl sensitization
on the grafted skin dramatically enhanced the production of
IL-10. This increase of IL-10 was considered to be derived
from LCs or proliferative T cells in the draining lymph nodes.
As the PCl-painted grafted skin produced less IL-10 than the
PCl-non-painted grafted skin (see Figure 3a), we postulate
that IL-10-producing LCs emigrated from the grafted skin to
the lymph nodes on sensitization with PCl.
LCs as a source of IL-10 in grafted skin
To dissect the cytokine-producing populations in grafted skin,
EC and dermal cell suspensions were prepared from grafted
(day 7) or normal skin. EC suspensions and dermal cell
suspensions were fractionated to CD11cþ (containing
70–80% LCs or dDCs and o0.01% T cells) and CD11c
(containing mainly keratinocytes or fibroblasts and o0.05%
DCs) subsets with magnetic cell sorting (MACS). As shown in
Figure 5, both CD11cþ and CD11c fractions produced a
high amount of IL-10, indicating that not only keratinocytes
but also LCs from the grafted skin were stimulated to produce
IL-10. In contrast, CD11c cells secreted more IL-6 in grafted
skin than normal skin, suggesting that keratinocytes in the
graft produced IL-6. Both CD11cþ and CD11c cells
produced higher amounts of tumor necrosis factor-a (TNF-
a) in the grafted skin than in the normal skin. Surgical trauma
induces an early hyperinflammatory response, which is
characterized by proinflammatory TNF-a, IL-1, and IL-6
cytokine release (Menger and Vollmar, 2004). IL-6 has a
crucial role in the neutrophil and macrophage infiltration in
the wound healing process (Lin et al., 2003). Thus, this
increase of IL-6 and TNF-a is considered to be a hyperin-
flammatory response of the wound healing process.
Induction of CD4þCD25þ regulatory T cells by sensitization
through grafted skin
The presence of IL-10-producing LCs in the epidermis and
lymph nodes raised the possibility that Treg cells were
induced in mice sensitized with PCl through grafted skin. We
performed an adoptive transfer study to evaluate this
possibility. Donor mice were sensitized with PCl on the
grafted skin, and lymph nodes and spleen cells were taken
from the mice 5 days later (Figure 6, top). CD4þCD25þ and
CD4þCD25 subsets were purified from the pooled cells by
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Figure 5. Cytokine production by ECs and dermal cells. EC suspensions were
obtained from grafted or non-grafted skin, and fractionated to CD11cþ cells
(70–80% LCs) and CD11c cells (LC-depleted cells, mainly keratinocytes)
with auto-MACS using CD11c microbeads. Dermal cell suspensions were
centrifuged with Ficoll-Paque, followed by auto-MACS, to fractionate dDCs
and other cells (mainly fibroblasts). Each subset was cultured for 24 hours. The
amounts of IL-4, IL-6, IL-10, IL-12, and TNF-a in the culture supernatants were
quantified using cytometric beads array. Data are the mean±SD of three
independent experiments. Each group consisted of more than four mice.
*Po0.05.
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24hours later. Each group consisted of more than four mice. Data are
representative of three independent experiments. *Po0.05.
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MACS. Whole unfractionated cells or cells of each subset
were transferred into syngeneic naive recipients (5 106 for
each mouse), which were then sensitized and challenged
with PCl. The transfer of CD4þCD25þ T cells decreased the
CHS response of the recipients, whereas CD4þCD25 T cells
were not suppressive (Figure 6, bottom). When recipient mice
were sensitized and challenged with another hapten dinitro-
fluorobenzene, such suppression was not observed, suggest-
ing that the immunosuppression was antigen specific. Thus,
the depressed sensitization through the grafted skin was
associated with the appearance of CD4þCD25þ Treg cells.
Augmentation of IL-10 production by LCs exposed to RANKL
It has been recently reported that LCs express receptor
activators of nuclear factor k-B, that UVB irradiation
upregulates cutaneous RANKL, and that RANKL activates
DCs as well as Tregs in the skin (Loser et al., 2006). We
hypothesized that the grafted skin expresses RANKL and
activates LCs to produce IL-10. When the grafted skin was
stained with anti-RANKL and MHC class II antibodies,
we found that ECs of the grafted skin expressed RANKL
(Figure 7a, RANKL, blue; LCs, red). Notably, RANKL was
strongly expressed around LCs (merged purple), suggesting
that receptor activators of nuclear factor k-B/RANKL interac-
tions might be important for the induction of hyposensitiza-
tion in grafted skin. To identify the function of receptor
activator of nuclear factor k-B/RANKL in the skin immune
system, we tested the ability of LCs to produce IL-10 when
they were exposed to recombinant RANKL. EC suspensions
were cultured with or without recombinant RANKL (R&D
Systems, McKinley, MN) for 24 hours, and stained with anti-
MHC class II antibody. Then, the cells were permeabilized
and stained with anti-IL-10 antibody. We found that the
addition of RANKL increased the fraction of IL-10-positive
LCs (Figure 6b) and the mean fluorescence intensity of IL-10
in LCs (Figure 6c). These findings indicated that RANKL
expressed by keratinocytes of grafted skin stimulates LCs to
produce IL-10.
DISCUSSION
This study addressed the immunological mechanism under-
lying impaired sensitization through grafted skin. CHS was
depressed only when mice were immunized with hapten
through grafted skin, and even skin graft-bearing mice fully
developed CHS when sensitized through non-grafted skin.
Therefore, the induction of immunosuppression is local,
whereas its effects are specific. The local immunological
condition of the grafted skin is responsible for impaired
induction. The fate of LCs in the graft seems to be a key to
resolving the mechanism. Mainly because of the apoptotic
death of LCs, the number of LCs in freshly implemented skin
was up to one-fourth that of normal skin. However, when
FITC was applied to the grafted skin, FITC-bearing LCs were
present in the draining lymph nodes, again at a cell number
one-fourth that of normal skin–sensitized mice. Thus, LCs
were capable of migrating efficiently from the grafted skin to
the draining lymph nodes. As LCs can serve as both positive
and negative antigen-presenting cells depending on the
surrounding milieu (Silberberg-Sinakin and Thorbecke,
1980; Kaplan et al., 2005), not only the numerical but also
functional changes of LCs determine CHS development. We
further investigated whether the hyposensitization of CHS
through grafted skin was attributable merely to the reduction
of LC number, or whether some function of LCs was altered.
DCs in peripheral tissues, such as epidermal LCs, remain
immature in the steady state, and express small quantities of
MHC class II and co-stimulatory molecules and produce low
levels of immunostimulatory cytokines. During the process of
antigen capture/presentation and migration into T-cell areas
of regional lymph nodes, maturation of DCs simultaneously
occurs, as they express high amounts of these surface
molecules and cytokines (Inaba et al., 1997; Huang et al.,
2000; Lutz and Schuler, 2002). Recent studies have revealed
that peripheral tolerance is induced by immature DCs
(Steinman et al., 2000; Lutz and Schuler, 2002) or partially
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Figure 7. Induction of RANKL in grafted skin and stimulation of LCs to
produce IL-10 by RANKL. (a) The grafted or non-grafted skin was stained with
antibodies to MHC class II and RANKL. Red, MHC-class II; blue, RANKL.
Merged image is shown in purple. (b, c) EC suspensions were cultured with or
without recombinant RANKL for 2 days. Cells were fixed, permeabilized,
stained with IL-10 and MHC class II antibodies, and analyzed by flow
cytometry (b). The mean fluorescence intensity of IL-10 in MHC class IIþ LCs
existing in EC suspensions. Bars indicate the meanþ SD. Data are
representative of three independent experiments. Each group consisted of
more than four mice. Scale bar¼ 50 mm *Po0.05.
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by mature DCs that express MHC class II, CD80 and CD86
molecules but lack secretion of IL-12, IL-6, and TNF-a
(Groux, 2003). On the basis of their migrating ability, it
seemed that nonapoptotic, live LCs in the grafted skin were
functionally mature.
Given that surgical trauma is one of the injuries that
induce a hyperinflammatory response, the skin graft em-
ployed in this study likely leads to the production of
proinflammatory cytokines such as TNF-a and IL-6. However,
the skin graft is not merely surgical trauma, because living
skin is applied to the raw surface. More specifically, the intact
ECs produce high amounts of IL-6 and TNF-a (see Figure 5),
suggesting that skin grafting induces inflammatory cytokine
production more vigorously than simple trauma. In wound
healing after skin grafting, the exaggerated inflammatory
response should be downregulated in due course. Among
various factors that suppress the inflammatory response, IL-10
is one of the most important candidates, because it is a potent
inhibitor of the activation of monocytes/macrophages and of
the expression of TNF-a and other proinflammatory media-
tors (Denys et al., 2002). In fact, IL-10 was produced at a high
level by keratinocytes in grafted skin. We explored the
possibility that LCs have a polarized cytokine production
pattern in the graft, which leads to peripheral tolerance.
In this scenario, IL-10 is a strong candidate as a skewing
cytokine.
LCs in grafted skin exhibited a rounder and less dendritic
appearance than those in normal skin. Along with this
morphological change, LCs in grafted skin expressed IL-10 at
a higher level than those in non-grafted skin, suggesting that
IL-10-producing LCs have an important role in depressed
CHS. Many studies have shown that IL-10 is an essential
cytokine in depression of CHS (Annacker et al., 2001;
Girolomoni et al., 2004; Ghoreishi and Dutz, 2006).
Similarly, IL-10 production by pulmonary DCs is critical for
the induction of tolerance (Akbari et al., 2001). Besides LCs,
keratinocytes also secrete IL-10, which causes CHS suppres-
sion when overexpressed by certain stimuli such as UVB
radiation (Schwarz et al., 2004; Ghoreishi and Dutz, 2006).
Keratinocyte-derived IL-10 might further condition LCs to be
regulatory as well as suppress the injury-associated inflam-
mation.
Conversely, the adoptive transfer of CD4þCD25þ T cells
from the tolerant mice induced CHS suppression, whereas
CD4þCD25 T cells had no effect. This suggests that
CD4þCD25þ Treg cells as well as IL-10-producing LCs
participate in the skin graft–induced suppression of CHS. At
present, at least four types of Treg cells can be identified
based on the expression of cell-surface markers, secretion of
cytokines, and suppression mechanisms (Groux, 2003).
Recent accumulating evidence has indicated that Treg cells
have a key role in peripheral tolerance (Takahashi et al.,
1998; Shevach, 2001; Taylor et al., 2001; Thorstenson and
Khoruts, 2001; Zhang et al., 2001) under the influence of
immature or maturing DCs (Min et al., 2003; Roelofs-
Haarhuis et al., 2003).
The relationship between IL-10-producing LCs and Treg
cells remains partly elucidated. In UVB-induced tolerance,
intravenous transfer of Treg cells suppresses CHS, and this
phenomenon is dependent on host-derived IL-10 (Ghoreishi
and Dutz, 2006). Other groups have reported that Treg cells
regulate the expansion of peripheral CD4þ T cells with IL-10
(Annacker et al., 2001). These findings have suggested that
IL-10 is essential for Treg cells for successful downmodula-
tion, and the source of IL-10 is a constituent of the
immunological milieu, such as epithelial cells, or Treg cells
per se. However, we found that LCs are the IL-10 producer,
raising the possibility that IL-10-producing LCs are an inducer
of Treg cells. In addition, IL-10 released from LCs also might
inhibit effector T cells concerned with CHS.
A group of investigators have found that RANKL, which
is expressed in the keratinocytes of inflamed skin,
controls Treg cell numbers by activation of DCs (Loser
et al., 2007). In this study, we showed that both epidermal
CD11cþ LCs and CD11c cells (keratinocytes) produce
high amounts of representative proinflammatory cytokine
TNF-a in the grafted area, which might lead to the expression
of RANKL on keratinocytes. Our finding that LCs exposed
to recombinant RANKL produced a high level of IL-10
suggests that RANKL from keratinocytes in the grafted skin
can induce IL-10-producing LCs at the initiation stage of
immunosuppression. The reduction in LC number may cause
impaired sensitization, but in accordance with recent
observations (Kaplan et al., 2005; Kissenpfennig et al.,
2005), the altered function of LCs is more likely involved in
the depression of CHS.
Our study is clinically relevant in two aspects. First,
grafted skin provides a specialized immunological status, in
which T cells do not respond well to external stimuli such as
contactants, as a result of skewed function and a reduced
number of LCs. In this context, contact dermatitis cannot
easily develop in the grafted skin. Second, the skin graft may
be used for the induction of antigen-specific peripheral
tolerance by application of antigen through the grafted skin.
This strategy may have great potential for controlling allergic
diseases and autoimmune disorders. Further investigation of
this skin graft-associated immunosuppression may develop
safe and effective methodologies for tolerance induction.
MATERIALS AND METHODS
Mice
BALB/c (7- to 10-week-old) female mice were obtained from
Kyudo Co. Ltd (Kumamoto, Japan). Mice were maintained on a
12-hour light/dark cycle under specific pathogen-free conditions.
Protocols were approved by the Institutional Animal Care and Use
Committee of the University of Occupational and Environmental
Health.
Preparation of skin graft
One day before skin grafting, the back of each mouse was clipped
and hairs were removed with depilatory cream (Shiseido Cosmetic
Co., Tokyo, Japan). A 25 20mm area of full-thickness back skin
was resected under intraperitoneal anesthesia with ketamine and
dolmicam. The same skin was grafted onto the back of each mouse.
The graft was sutured and fixed with a tie-over dressing. The dressing
was removed on day 7 after operation.
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Contact hypersensitivity
For contact sensitization, 25ml of PCl solution (0.5% w/v in acetone-
olive oil mixed at 4:1) was painted on the grafted or non-grafted
area. For elicitation, 10 ml of 0.2% PCl solution was painted on each
earlobe of the PCl-sensitized mice on day 5 after sensitization. In
some experiments, 50 ml of dinitrofluorobenzene (Nacalai Tesque
Co., Tokyo, Japan) solution (0.5% w/v in acetone–olive oil mixed at
4:1) was painted on the abdomen, and elicited with 10 ml of 0.3%
dinitrofluorobenzene solution on each earlobe 5 days after
sensitization. The thickness of each ear was measured with a
micrometer 24 hours after elicitation. Swelling was expressed as the
increase in ear thickness.
Culture medium
RPMI 1640 (Gibco BRL Life Technology, Grand Island, NY) was
supplemented with 10% heat-inactivated fetal calf serum, 2mM
L-glutamine, 5 105 M 2-mercaptoethanol, 105 M sodium pyru-
vate, 25mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 1%
nonessential amino acids, 100Uml1 penicillin, and 100 mgml1
streptomycin (all from Gibco BRL Life Technology).
Immunohistochemistry
For immunofluorescence analysis, epidermal sheets were
separated from the dermis with 0.5M ammonium thiocyanate, fixed
in acetone for 5minutes at 20 1C, and stained with PE-conjugated
anti-I-Ad mAb (BD Biosciences, San Diego, CA). In some
experiments, the back skin of mice was frozen in Tissue-Tek OCT
compound 4583 (Sakura Finetechnical Co. Ltd, Tokyo, Japan).
Cryostat sections (10 mm) were fixed in acetone and stained with PE-
conjugated anti-I-Ad mAb, biotin-conjugated anti RANKL mAb (R&D
Systems) followed by staining with allophycocyanin-Cy7 conjugated
streptavidin. Images were viewed with a Zeiss confocal microscope
and processed with an LSM Image Browser (Zeiss).
Preparation of EC and dermal cell suspensions, and purification
for LCs and dDCs
Skin sheets were floated in 0.2% trypsin in phosphate-buffered saline
(pH 7.4) for 1 hour at 37 1C as described previously (Tokura et al.,
1994). The epidermis was separated from the dermis with forceps
in phosphate-buffered saline supplemented with 10% fetal calf
serum. EC suspensions were prepared by pipetting and filtration
through nylon mesh. Dermal cells were obtained from normal or
grafted skin from which the epidermis had been removed. Samples
were minced and incubated for 2 hours at 37 1C in RPMI 1640
(Invitrogen, Carlsbad, CA) supplemented with collagenase XI
(4,830Uml1; Sigma, Tokyo, Japan), hyaluronidase (260Uml1;
Sigma), DNase (0.1mgml1; ICN, Costa Mesa, CA), and 10mM 4-(2-
hydroxyethyl)-1-piperazine ethanesulfonic acid (Sigma). The ob-
tained cells were filtered through a 40mm filter. dDCs and other cells
(mainly fibroblasts) were fractionated from the dermal cell suspen-
sions with Ficoll-Paque (GE Healthcare UK Ltd) For enrichment of
LCs and dDCs, EC suspensions and derma cell suspensions after
Ficoll-Paque fractionation were purified for CD11cþ and CD11c
subsets using anti-CD11c mAb and auto-MACS (Miltenyi Biotec,
Gladbach, Germany). The purity of CD11cþ cells was 70–80%
(Supplementary information, Figure S1), containing less than 0.01%
CD3þ T cells as determined by flow cytometric analysis. The
CD11c cells from EC and dermal cell suspensions were mainly
keratinocytes and fibroblasts, respectively, containing less than
0.05% DC subsets.
Flow cytometry
Cells were immunostained with various combinations of fluores-
cence-conjugated mAbs and analyzed with three-channel FACS-
Canto flow cytometer (BD Biosciences) and FlowJo software (Tree
Star Inc, Ashland, OH). The expression of cell-surface and
intracytoplasmic cytokines were analyzed using antibodies to PE-
conjugated anti-CD11c, CD80, CD86 and PE-conjugated anti-rat
IgG, purified anti-mouse CD205 (DEC205) rat IgG, PerCP-conju-
gated anti-CD45R mAbs, PE-conjugated anti-MHC class II, biotin-
conjugated anti-IL-10, and PE-Cy7-conjugated streptavidin. Anti-
bodies were purchased from e-Bioscience (San Diego, CA). All mAbs
were used at 1–5 mg 106 cells, and each incubation was performed
for 30minutes at 4 1C, followed by two washes in phosphate-
buffered saline supplemented with 5% fetal calf serum and 0.02%
sodium azide. Viable cells were identified by 7-AAD uptake.
Intracytoplasmic IL-10 was detected in permeabilized cell suspen-
sions using BD Cytofix/Cytoperm Plus Kit (BD Biosciences).
Apoptosis analysis
EC suspensions from control or grafted (1, 4, and 7 days after) skin
were stained with FITC-conjugated MHC-class II mAb for 30minutes
on ice and stained with allophycocyanin-conjugated Annexin V and
propidium iodide (Invitrogen), according to the manufacturer’s
protocol. Apoptosis in LCs was analyzed by a FACScant using
FlowJo software (Tree Star Inc) as described earlier (Goldszmid et al.,
2003).
Cutaneous DC migration into draining lymph nodes
Mice were painted with 200ml of 2% FITC (Sigma-Aldrich, St Louis,
MO), and axillar and inguinal lymph nodes were taken 24 hours
later. Single-cell suspensions were prepared and subjected to flow
cytometric analysis.
Real-time PCR
Total RNA was extracted from axillary and inguinal lymph nodes
and EC suspensions with the SVTotal RNA isolation system
(Promega, Madison, WI) according to the manufacturer’s protocol.
Murine IL-10 gene expression was quantified in a two-step reverse
transcription–PCR. cDNA was reverse transcribed from total RNA
samples using the TaqMan RT reagents (Applied Biosystems, Foster,
CA). Target gene expression was quantified using TaqMan Gene
Expression Assay (Applied Biosystems) in the ABI PRISM 7000
sequence detection system (Applied Biosystems). The probe was
synthesized with VIC as the reporter dye and Tamra as the quencher
dye. The forward primer, reverse primer, and TaqMan probe were
purchased from Applied Biosystems. As an endogenous control for
these PCR quantification studies, glyceraldehyde-3-phosphate dehy-
drogenase gene expression was measured using the TaqMan rodent
GAPDH control reagents (Applied Biosystems). Results represented
normalized IL-10 mRNA amounts relative to skin-grafted groups
using the DDCt method.
Measurement of cytokine amounts in culture supernatants
CD11cþ and CD11c cells were purified from EC and dermal cell
suspensions. Cells of each subset (2 106 cells per 1.5ml well) were
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cultured in medium for 24 hours in 24-well plates (Corning Glass
Works, Corning, NJ). The concentration of IL-4, IL-6, IL-10, IL-12,
and TNF-a in culture supernatants was measured using a cytometric
beads array system (BD Biosciences) according to the manufacturer’s
protocol.
Purification and adoptive transfer of Treg cells
Axillary and inguinal lymph nodes were harvested from mice. They
were meshed through a cell strainer into RPMI 1640 containing 2%
fetal calf serum to prepare single-cell suspensions. To purify
CD4þCD25þ cells or CD4þCD25 cells, a mouse Treg isolation
kit (Miltenyi Biotec) was used according to the manufacturer’s
protocol. Briefly, CD4 cells were depleted with the biotin-
labeled antibody cocktail. Subsequently, the CD4þ fractions
were magnet-separated with CD25-PE mAb. The positive fraction
contained CD4þCD25þ cells with more than 95% purity, and
the flow-through fractions from magnet columns were used as
CD4þCD25 fraction.
Statistic analysis
All data were statistically analyzed using Student’s t-test. A P-value
of less than 0.05 was considered to be significant. Bar graphs were
presented as mean±SD of the mean value.
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